Medications

FDA OKs first treatment for rare genetic disorder

The Food and Drug Administration on Friday approved the first treatment for children and adults with spinal muscular atrophy, a rare genetic disorder marked by progressive muscle weakness that's the most common genetic cause ...

Arthritis & Rheumatism

Knee cartilage product approved to repair defects

(HealthDay)—Maci (autologous cultured chondrocytes) has been approved by the U.S. Food and Drug Administration to repair defective cartilage of the knee.

Medical research

Tongue-on-a-chip provides insight into genetic diseases

Muscular dystrophy is a group of rare genetic diseases that cause progressive muscle weakness and deterioration. For decades, researchers have struggled to understand how the disease works and to find suitable treatments.

Neuroscience

Simple urine test for motor neurone disease

A researcher at Flinders University has developed a simple urine test that gives a quantitative measure of the severity of motor neurone disease.

page 17 from 28